Free Communications - Screening 1

Sunday, December 2, 2018
Free Communications
FC 01 8:30 AM > 10:30 AM Free Communications - Screening 1 Auditorium II

8:30 AM FC 01-01 Screening of cervical cancer in women aged 30 to 64 years screened with human papillomavirus tests (ESTAMPA* study). Experience in Paraguay > L. L Mendoza 8:38 AM FC 01-02 Accuracy of high-risk HPV testing and HPV16/18 genotyping to triage women with LSIL: a pooled analysis of VALGENT studies > L. Lan XU 8:46 AM FC 01-03 HPV- DNA primary screening in Israel decreased colposcopy referrals. The experience of Maccabi Health Medical Organization > E. Eduardo Schejter 8:54 AM FC 01-04 Risk of CIN2+ after a negative 1-yr recall HPV test in HPV-positive women with normal cytology attending HPV cervical screening > A. ANNAROSA Del Mistro 9:02 AM FC 01-05 Implementation of primary HPV mRNA screening for cervical cancer: first year experiences > O. Ola Forslund 9:10 AM FC 01-06 A risk-based approach: co-testing 34 612 women with cytology and 3-type HPV mRNA test > S. Sveinung Wergeland Sorbye 9:18 AM FC 01-07 Primary cervical cancer screening with a 5-type HPV E6/E7 mRNA test: results of 10 years follow-up > S. Siri Hovland 9:26 AM FC 01-08 Absolute and relative risk of CIN2/3+ in women ascus HPV16/18+ versus ascus 12other HRHPV+: baseline results of the compact study > S. Sharon Hanley 9:34 AM FC 01-09 mRNA HPV E6/E7 screening: a 3-year longitudinal cotest study in Madrid. Preliminary results > R. Rosario Granados 9:42 AM FC 01-10 p16/Ki-67 and HPV as triage tests in routine screening: correlation with histology > A. ARJOLA Xhaja 9:50 AM FC 01-11 Much lower rate of limited and insufficient smears with LBC (THINPREPTM) than with conventional cytology. Experience in routine > H. Hans Ikenberg 9:58 AM FC 01-12 CERVIVA HPV primary screening pilot study: evaluation of triage strategies for HPV-positive women > C. Cara Martin 10:06 AM FC 01-13 3-type HPV mRNA test in detection of CIN2+ in young women with normal cytology > K. Khalid Al-Shibli 10:14 AM FC 01-14 Online platform for monitoring of cervical screening programmes in the Nordic countries > V-M. Veli-Matti Partanen

Copyright © key4events - All rights reserved